2 studies found for:    2034244 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Abraxane;   Drug: Cetuximab;   Drug: Cisplatin;   Drug: 5-FU;   Radiation: Radiation (Post induction)
2 Recruiting INDUCTION CHEMOTHERAPY FOLLOWED BY CETUXIMAB AND RADIATION THERAPY FOR HEAD AND NECK CANCER
Condition: Head and Neck Cancer
Interventions: Radiation: Radiotherapy;   Drug: Leucovorin;   Biological: Cetuximab;   Drug: Filgrastim;   Drug: Erythropoetin;   Drug: Cisplatin;   Drug: Fluorouracil;   Drug: Docetaxel

Indicates status has not been verified in more than two years